Cargando…
Effect of Differences in the Microbiome of Cyp17a1-Deficient Mice on Atherosclerotic Background
CYP17A1 is a cytochrome P450 enzyme that has 17-alpha-hydroxylase and C17,20-lyase activities. Cyp17a11 deficiency is associated with high body mass and visceral fat deposition in atherosclerotic female ApoE knockout (KO, d/d or −/−) mice. In the present study, we aimed to investigate the effects of...
Autores principales: | Künstner, Axel, Aherrahrou, Redouane, Hirose, Misa, Bruse, Petra, Ibrahim, Saleh Mohamed, Busch, Hauke, Erdmann, Jeanette, Aherrahrou, Zouhair |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224745/ https://www.ncbi.nlm.nih.gov/pubmed/34070975 http://dx.doi.org/10.3390/cells10061292 |
Ejemplares similares
-
Identification of a novel ovine LH-beta promoter region, which dramatically enhances its promoter activity
por: Aherrahrou, Redouane, et al.
Publicado: (2015) -
CYP17A1 deficient XY mice display susceptibility to atherosclerosis, altered lipidomic profile and atypical sex development
por: Aherrahrou, Redouane, et al.
Publicado: (2020) -
Dare to Compare. Development of Atherosclerotic Lesions in Human, Mouse, and Zebrafish
por: Vedder, Viviana L., et al.
Publicado: (2020) -
Induced Pluripotent Stem Cells (iPSCs) in Vascular Research: from Two- to Three-Dimensional Organoids
por: Trillhaase, Anja, et al.
Publicado: (2021) -
Etidronate prevents dystrophic cardiac calcification by inhibiting macrophage aggregation
por: Bauer, Carolin, et al.
Publicado: (2018)